Biohaven Ltd [BHVN] stock is trading at $15.11, up 13.10%. An important factor to consider is whether the stock is rising or falling in short-term value. The BHVN shares have gain 0.53% over the last week, with a monthly amount drifted -0.46%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Biohaven Ltd [NYSE: BHVN] stock has seen the most recent analyst activity on May 19, 2025, when RBC Capital Mkts downgraded its rating to a Sector Perform but kept the price target unchanged to $21 for it. Previously, Deutsche Bank started tracking the stock with Buy rating on February 11, 2025, and set its price target to $65. On September 16, 2024, Jefferies initiated with a Buy rating and assigned a price target of $57 on the stock. Bernstein started tracking the stock assigning a Outperform rating and suggested a price target of $55 on September 04, 2024. Morgan Stanley initiated its recommendation with a Overweight and recommended $58 as its price target on July 24, 2024. RBC Capital Mkts started tracking with a Outperform rating for this stock on February 16, 2024, and assigned it a price target of $62. In a note dated February 06, 2024, UBS initiated an Buy rating and provided a target price of $59 on this stock.
Biohaven Ltd [BHVN] stock has fluctuated between $13.04 and $55.70 over the past year. Currently, Wall Street analysts expect the stock to reach $58.5 within the next 12 months. Biohaven Ltd [NYSE: BHVN] shares were valued at $15.11 at the most recent close of the market. An investor can expect a potential return of 287.16% based on the average BHVN price forecast.
Analyzing the BHVN fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -1.94, Equity is -2.57 and Total Capital is -3.13. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.12.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
For context, Biohaven Ltd’s Current Ratio is 2.33. On the other hand, the Quick Ratio is 2.33, and the Cash Ratio is 0.6.
Transactions by insiders
Recent insider trading involved CHILDS JOHN W, Director, that happened on Mar 04 ’25 when 32700.0 shares were purchased. Director, CHILDS JOHN W completed a deal on Dec 30 ’24 to buy 29000.0 shares. Meanwhile, Director CHILDS JOHN W bought 21052.0 shares on Oct 02 ’24.